Joelle A. Hallak

Jul 11, 2024 | jamanetwork.com | Joelle A. Hallak |Outcomes Research |Ali Abbasi |Currently with

Key PointsQuestion  Are Janus kinase inhibitors (JAKis) in autoimmune diseases associated with a reduction in age-related macular degeneration (AMD)? Findings  Using MarketScan and Optum administrative claims data (2010-2022), this cohort study compared AMD incidence among 29 586 propensity score–matched patients who received JAKi-based immunotherapy vs non–JAKi-based immunotherapy for autoimmune diseases.